The Shanghai Shenzhen CSI 300 and Shanghai Composite indexes fell 0.8% and 0.6%, respectively, Hang Seng index slumped nearly 2% and Japan’s Nikkei 225 index fell 0.2%
Most Asian stock markets retreated on Monday as investors pivoted out of risk-heavy assets ahead of more signals on U.S. monetary policy this week, while rising COVID-19 cases in China dampened optimism over an economic reopening in the country.
Chinese and Hong Kong stocks were the biggest decliners on the day as markets feared that the relaxing of anti-COVID measures in China will result in much higher infection rates. China is already struggling with a record-high increase in daily infections.
This largely offset optimism over a potential economic recovery in the country, with the withdrawal of COVID curbs.
The Shanghai Shenzhen CSI 300 and Shanghai Composite indexes fell 0.8% and 0.6%, respectively, while Hong Kong’s Hang Seng index slumped nearly 2%. Analysts also forecast high volatility in Chinese markets as the country relaxes anti-COVID measures.
Japan’s Nikkei 225 index fell 0.2% after data showed producer price inflation in the country remained pinned near 40-year highs in November. The reading shows that price pressures are likely to remain more stubborn and pressure the Japanese economy in the near-term.
India’s Nifty 50 and BSE Sensex 30 indexes were flat on Monday ahead of key consumer inflation data due later in the day, which is expected to show that price pressures eased further in the country.
Focus this week is squarely on key U.S. consumer price index (CPI) inflation data due on Tuesday. While the data is expected to show that inflation eased further in November, stronger-than-expected producer price index inflation for the month may herald a similar trend in consumer prices.
The data is expected to largely factor into the Fed’s stance on monetary policy. The central bank is set to hike interest rates by 50 basis points at the conclusion of a two-day meeting on Wednesday.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.